Daniel Lorrain
Vermogen: 2 M $ op 30-06-2026
Vermogen: 2 M $ op 30-06-2026
Daniel S.
Lorrain is the founder of Contineum Therapeutics, Inc., founded in 2017, serving as Chief Scientific Officer since 2018.
Former jobs include Senior Director at Amira Pharmaceuticals, Inc. from 2005 to 2010, and Vice President-Biology at Inception Sciences, Inc. from 2016 to 2018.
Education includes an undergraduate degree conferred in 1991 and a doctorate conferred in 1997, both from the State University of New York at Buffalo.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 09-07-2026 | 145.312 ( 0,44% ) | 2 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Oprichter | 09-05-2017 |
| Bedrijven | Functie | Einde |
|---|---|---|
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Directeur/Bestuurslid | 10-01-2018 |
Amira Pharmaceuticals, Inc.
Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Directeur/Bestuurslid | 01-11-2010 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Amira Pharmaceuticals, Inc.
Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
State University of New York at Buffalo
State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Health Technology |
Pipeline Therapeutics, Inc.
Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau